8th Annual Jordan Driggers
Hook A Cure Fishing Tournament 2011
benefiting the Cystic Fibrosis Foundation

Partner with the CF Foundation

Since 1955, the mission of the Cystic Fibrosis Foundation is to assure the development of the means to cure and control cystic fibrosis (CF) and to improve the quality of life for those with the disease.The CF Foundation tirelessly pursues its mission by supporting scientific research, which is dedicated to the discovery and development of new therapies. At the same time, it funds and accredits a network of specialized treatment centers that provide state-of the-art care for people with CF. By applying the same principles that a for-profit company follow - efficiency, innovation and a results-driven approach - the CF Foundation is making a profound difference in the lives of those with CF.


The CF Foundation Is Efficient.

The Foundation is one of the most effective and efficient organizations of its kind. It has received a four-star rating for sound fiscal management from Charity Navigator, the largest independent charity evaluator in the United States, and is an accredited charity of the Better Business Bureau's Wise Giving Alliance.


The CF Foundation Is Innovative.

To quicken the pace of drug discovery and development, the Foundation has pioneered an innovative and highly effective business model the Foundation has committed hundreds of millions of dollars in collaboration with the biotech industry to fuel the search for new treatments and a cure. The Foundation's unique approach to drug discovery has yielded a therapeutics pipeline with more than 30 potential therapies in development for CF.

Virtually every approved CF drug available today was made possible because of Foundation support. Since the 1980s, the Foundation has played an integral role in the development of Pulmozyme®, TOBI®, azithromycin and hypertonic saline, essential drugs for the treatment of CF.


The CF Foundation Is Results-Driven.

The Cystic Fibrosis Foundation has fueled dramatic improvements in research and care that have significantly changed the prognosis for people with CF. When the CF Foundation began, few children lived to attend elementary school. Thanks to the research and care supported by the CF Foundation, the median age of survival for a person with CF is now 38 years. For the first time in the history of the disease, CF clinical trial participants are taking oral drugs aimed at treating the basic defect in CF (a faulty protein). If successful, these drugs could add decades of life for people with the disease.

The Foundation continues to be a strong and focused organization: 2008 was a banner year in terms of scientific and medical progress. As we look ahead, we are working more proactively and thinking more creatively than ever before. Although the outlook for a child born with CF today has improved tremendously over the years, it is not good enough. Your involvement and financial support are critical to our success. Working together, we can add tomorrows every day to the lives of all people with CF.

About Cystic Fibrosis

CF is a life-threatening genetic disease that affects the lungs and digestive systems of approximately 30,000 children and adults in the United States (70,000 worldwide). One in 32 Americans (more than 10 million people) is an unknowing, carrier of the defective CF gene.

When the CF Foundation began, few children lived to attend elementary school. Today, thanks to the efforts of scientists and caregivers supported by the CF Foundation, the median age of survival for a person with CF is in the early thirties. In fact, nearly 40 percent of the CF patient population is age 18 and older. This is a remarkable improvement, but it is not good enough, as we continue to lose at least one precious life to CF every day.